THE ROLE OF METABOLIC SURGERY FOR PATIENTS WITH OBESITY GRADE I AND TYPE 2 DIABETES NOT CONTROLLED CLINICALLY.

scientific article published on January 2016

THE ROLE OF METABOLIC SURGERY FOR PATIENTS WITH OBESITY GRADE I AND TYPE 2 DIABETES NOT CONTROLLED CLINICALLY. is …
instance of (P31):
scholarly articleQ13442814
review articleQ7318358

External links are
P356DOI10.1590/0102-6720201600S10025
P932PMC publication ID5064276
P698PubMed publication ID27409057

P2093author name stringBruno Zilberstein
Almino Ramos
Josemberg Campos
Ricardo Cohen
Heládio Feitosa
Thomaz Szego
P2860cites workDiagnosis and classification of diabetes mellitusQ28280909
Host-gut microbiota metabolic interactionsQ29615104
Human gut microbiota in obesity and after gastric bypassQ29615813
Is the gut the "sweet spot" for the treatment of diabetes?Q53039300
Gastrointestinal surgery as a treatment for diabetes.Q55048043
The Role of β-Cell Function and Insulin Sensitivity in the Remission of Type 2 Diabetes after Gastric Bypass SurgeryQ59297368
Effect of Bariatric Surgery vs Medical Treatment on Type 2 Diabetes in Patients With Body Mass Index Lower Than 35: Five-Year OutcomesQ86169332
Bariatric surgery: a systematic review and meta-analysisQ30769299
The relationship of body mass index to diabetes mellitus, hypertension and dyslipidaemia: comparison of data from two national surveysQ31112204
Bariatric surgery versus intensive medical therapy for diabetes--3-year outcomesQ33746480
Prevalence and correlates of inadequate glycaemic control: results from a nationwide survey in 6,671 adults with diabetes in BrazilQ33808461
Health outcomes of gastric bypass patients compared to nonsurgical, nonintervened severely obeseQ33828129
Differential adaptation of human gut microbiota to bariatric surgery-induced weight loss: links with metabolic and low-grade inflammation markersQ34024108
Bariatric surgery and prevention of type 2 diabetes in Swedish obese subjectsQ34033254
The mechanism of diabetes control after gastrointestinal bypass surgery reveals a role of the proximal small intestine in the pathophysiology of type 2 diabetesQ34576196
Jejunal proteins secreted by db/db mice or insulin-resistant humans impair the insulin signaling and determine insulin resistanceQ34598510
Bariatric surgery: an IDF statement for obese Type 2 diabetesQ35069674
Predictors of remission of diabetes mellitus in severely obese individuals undergoing bariatric surgery: do BMI or procedure choice matter? A meta-analysis.Q35383586
Glucagon-like peptide-1 and the islet beta-cell: augmentation of cell proliferation and inhibition of apoptosisQ35596396
Bariatric surgery versus intensive medical therapy in obese patients with diabetesQ36025669
Effects of gastric bypass surgery in patients with type 2 diabetes and only mild obesityQ36047225
A multisite study of long-term remission and relapse of type 2 diabetes mellitus following gastric bypass.Q36270273
Alterations in gastrointestinal, endocrine, and metabolic processes after bariatric Roux-en-Y gastric bypass surgeryQ36426666
Gastric bypass and banding equally improve insulin sensitivity and β cell functionQ36439877
Bariatric surgery: effects on glucose homeostasisQ36508543
Effect of weight loss by gastric bypass surgery versus hypocaloric diet on glucose and incretin levels in patients with type 2 diabetesQ36755303
Evaluation of current eligibility criteria for bariatric surgery: diabetes prevention and risk factor changes in the Swedish obese subjects (SOS) studyQ36782693
The prevalence of meeting A1C, blood pressure, and LDL goals among people with diabetes, 1988-2010.Q37022665
Endocrine mechanisms mediating remission of diabetes after gastric bypass surgeryQ37442596
Minireview: Hormonal and metabolic mechanisms of diabetes remission after gastrointestinal surgeryQ37446475
Beyond the BMI: the search for better guidelines for bariatric surgeryQ37691231
Diabetic and bariatric surgery: a review of the recent trends.Q37945106
Bariatric surgery in class I obesity (body mass index 30-35 kg/m²).Q38069671
Bariatric surgery in class I obesity : a Position Statement from the International Federation for the Surgery of Obesity and Metabolic Disorders (IFSO).Q38196736
Surgical versus medical treatment of type 2 diabetes mellitus in nonseverely obese patients: a systematic review and meta-analysisQ38269087
Legacy effects from DCCT and UKPDS: what they mean and implications for future diabetes trialsQ39854329
Roux-en-Y gastric bypass stands the test of time: 5-year results in low body mass index (30-35 kg/m(2)) Indian patients with type 2 diabetes mellitusQ44332299
Effect of Laparoscopic Roux-En Y Gastric Bypass on Type 2 Diabetes MellitusQ44609117
Long-term persistence of hormonal adaptations to weight lossQ47347342
Gut hormone profiles following bariatric surgery favor an anorectic state, facilitate weight loss, and improve metabolic parametersQ47356520
P275copyright licenseCreative Commons Attribution 4.0 InternationalQ20007257
P6216copyright statuscopyrightedQ50423863
P433issueSuppl 1
P921main subjectobesityQ12174
type 2 diabetesQ3025883
P304page(s)102-106
P577publication date2016-01-01
P1433published inArquivos brasileiros de cirurgia digestiva : ABCD = Brazilian archives of digestive surgeryQ26853858
P1476titleTHE ROLE OF METABOLIC SURGERY FOR PATIENTS WITH OBESITY GRADE I AND TYPE 2 DIABETES NOT CONTROLLED CLINICALLY.
P478volume29Suppl 1

Reverse relations

cites work (P2860)
Q89938058Gastro-ileal anastomosis bypass - Exploring for an expanding surgical treatment for diabetes in patients with low body mass index: Case series
Q47137951Jia-Wei-Jiao-Tai-Wan ameliorates type 2 diabetes by improving β cell function and reducing insulin resistance in diabetic rats
Q89491252Laparoscopic Adjustable Gastric Band and Type 2 Diabetes Mellitus
Q49304849THE ROLE OF THE SLEEVE GASTRECTOMY AND THE MANAGEMENT OF TYPE 2 DIABETES.
Q57098190The Impacts of Gastroileostomy Rat Model on Glucagon-like Peptide-1: a Promising Model to Control Type 2 Diabetes Mellitus
Q33889594The Role of Sleeve Gastrectomy on Preventing Type 2 Diabetes Mellitus

Search more.